|Bid||10.46 x 2900|
|Ask||10.85 x 900|
|Day's Range||10.48 - 10.82|
|52 Week Range||9.98 - 22.40|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for HRTXLearn more
These once-promising biotech stocks are trading at a fraction of their all-time highs right now.
Right now, markets are giving investors opposing trends simultaneously. The S&P and NASDAQ have posted strong year-to-date gains. At the same time, however, Wall Street strategists are growing more concerned that a slowing U.S. economy could derail the stock market’s record run. It’s an environment full of risk, and so risk-friendly investors are finding plenty of options – including short trading. Short trading is betting on the risks to play out; it’s buying into a position using borrowed shar
One thing we could say about the analysts on Heron Therapeutics, Inc. ( NASDAQ:HRTX ) - they aren't optimistic, having...